Additional file 1 of BluePrint molecular subtypes predict response to neoadjuvant pertuzumab in HER2-positive breast cancer

Authors :: Liefaard, M. C.
van der Voort, A.
van Ramshorst, M. S.
Sanders, J.
Vonk, S.
Horlings, H. M.
Siesling, S.
de Munck, L.
van Leeuwen, A. E.
Kleijn, M.
Mittempergher, L.
Kuilman, M. M.
Glas, A. M.
Wesseling, J.
Lips, E. H.
Sonke, G. S.
Publication Year :: 2023
Publisher :: figshare, 2023.
Abstract: Additional file 1. Supplementary Figures.

Full Text Access

Tools